PASQUINI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 478
EU - Europa 268
AS - Asia 94
AF - Africa 26
Totale 866
Nazione #
US - Stati Uniti d'America 474
IT - Italia 137
SE - Svezia 61
CN - Cina 36
SG - Singapore 33
BG - Bulgaria 21
GB - Regno Unito 21
CI - Costa d'Avorio 18
DE - Germania 14
VN - Vietnam 12
KR - Corea 7
SN - Senegal 5
CA - Canada 4
FI - Finlandia 3
IN - India 3
NG - Nigeria 3
AT - Austria 2
FR - Francia 2
NL - Olanda 2
UA - Ucraina 2
ID - Indonesia 1
IR - Iran 1
MD - Moldavia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 866
Città #
Fairfield 65
Woodbridge 63
Ann Arbor 45
Ashburn 45
Chandler 43
Milan 42
Houston 40
Seattle 33
Cambridge 27
Beijing 25
Sofia 21
Wilmington 20
Abidjan 18
New York 18
Pisa 11
London 10
Princeton 10
Lawrence 9
Florence 8
Lancaster 8
Des Moines 6
Singapore 6
Dakar 5
Frankfurt am Main 5
Rome 5
Bari 4
Medford 4
Ottawa 4
Piombino 4
Shenyang 4
Bremen 3
Dong Ket 3
Lagos 3
Los Angeles 3
Rocca Priora 3
Rosignano Marittimo 3
San Diego 3
Bitonto 2
Bologna 2
Düsseldorf 2
Genoa 2
Hebei 2
Kensington 2
Lugo 2
Nanjing 2
Naples 2
Redwood City 2
Romainville 2
Serra 2
Vienna 2
Avigliano 1
Bagni di Lucca 1
Bratislava 1
Casaleone 1
Catania 1
Changsha 1
Chisinau 1
Como 1
Ferrara di Monte Baldo 1
Garbagnate Milanese 1
Grafing 1
Hyderabad 1
Istanbul 1
Jakarta 1
Jiaxing 1
Kent 1
Livorno 1
Marina di Montemarciano 1
Massa 1
Minerbio 1
Mirano 1
New Albany 1
Ogden 1
Seacroft 1
Torino 1
Totale 680
Nome #
Second-line therapy for advanced pancreatic cancer: Evaluation of prognostic factors and review of current literature 125
Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer? 122
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study 110
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors 109
Pre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: a positive prognostic factor for survival? 101
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer 91
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 82
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan 81
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 61
Totale 882
Categoria #
all - tutte 2.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020156 0 12 7 9 12 16 18 18 17 14 25 8
2020/202196 6 8 7 2 1 9 9 6 10 12 9 17
2021/2022112 2 2 1 6 22 15 0 3 9 8 7 37
2022/2023178 18 36 15 4 14 20 1 12 37 1 18 2
2023/2024135 11 12 28 11 11 21 11 1 0 7 10 12
2024/20253 2 1 0 0 0 0 0 0 0 0 0 0
Totale 882